Physician profile
Weston Smith
NPI 1801473400
$7,856.30
in general payments reported to CMS, 2019-2025
8 companies · $3,823 in 2025
The $3,823 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,364 · 2023: $404 · 2024: $2,266 · 2025: $3,823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,950 · Food and Beverage: $1,574 · Travel and Lodging: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,950.00 |
| Food and Beverage | $1,574.31 |
| Travel and Lodging | $968.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $5,209.42 | 2024-2025 | Velys |
| Paladin Technology Solutions | $1,229.83 | 2022-2023 | |
| Stryker Corporation | $963.13 | 2022-2025 | Accolade, Mako, Gamma |
| Convatec INC. | $168.65 | 2025 | |
| Kuros Biosciences USA, INC | $142.84 | 2025 | Magnetos |
| Peter Brasseler Holdings, LLC | $101.74 | 2024 | |
| Orthofix Medical, INC. | $23.32 | 2023 | Physio-Stim |
| Depuy Synthes Sales INC. | $17.37 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weston Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.